The global targeted biomarker market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for personalized medicine.
The global targeted biomarker market is segmented on the basis of type, application, and region. On the basis of type, the market is categorized into safety biomarkers, efficacy biomarkers, validation biomarkers and targeted biomarkers. On the basis of application, it covers diagnostics development (drug discovery & development), personalised medicine (disease risk assessment). The regional segmentation includes North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases such as diabetes, obesity, and cardiovascular disease is driving the growth of the targeted biomarker market.
- The increasing number of clinical trials for targeted biomarkers is also driving the growth of this market.
- The growing demand for personalized medicine is also a major factor in the growth of this market.
- Increasing research and development activities in this field are also contributing to its growth.
- Increasing government funding for research and development activities in this field will drive its future growth.
Industry Growth Insights published a new data on “Targeted Biomarker Market”. The research report is titled “Targeted Biomarker Market research by Types (Safety biomarker, Efficacy biomarker, Validation biomarker, Targeted Biomarke), By Applications (Diagnostics development, Drug discovery & development, Personalized medicine, Disease risk assessment, Others), By Players/Companies bioMerieux, IntegraGen, Myriad Genetics, Protagen, Qiagen, PerkinElmer, Merck Millipore, Bio-Rad Laboratories, Enzo Biochem, EKF Diagnostics, Meso Scale Diagnostics, LLC., Targeted Biomarke”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Targeted Biomarker Market Research Report
By Type
Safety biomarker, Efficacy biomarker, Validation biomarker, Targeted Biomarke
By Application
Diagnostics development, Drug discovery & development, Personalized medicine, Disease risk assessment, Others
By Companies
bioMerieux, IntegraGen, Myriad Genetics, Protagen, Qiagen, PerkinElmer, Merck Millipore, Bio-Rad Laboratories, Enzo Biochem, EKF Diagnostics, Meso Scale Diagnostics, LLC., Targeted Biomarke
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Targeted Biomarker Market Report Segments:
The global Targeted Biomarker market is segmented on the basis of:
Types
Safety biomarker, Efficacy biomarker, Validation biomarker, Targeted Biomarke
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostics development, Drug discovery & development, Personalized medicine, Disease risk assessment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- bioMerieux
- IntegraGen
- Myriad Genetics
- Protagen
- Qiagen
- PerkinElmer
- Merck Millipore
- Bio-Rad Laboratories
- Enzo Biochem
- EKF Diagnostics
- Meso Scale Diagnostics, LLC.
- Targeted Biomarke
Highlights of The Targeted Biomarker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Safety biomarker
- Efficacy biomarker
- Validation biomarker
- Targeted Biomarke
- By Application:
- Diagnostics development
- Drug discovery & development
- Personalized medicine
- Disease risk assessment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Targeted Biomarker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Targeted biomarkers are specific molecules or proteins that can be used to diagnose, monitor, and treat diseases.
Some of the key players operating in the targeted biomarker market are bioMerieux, IntegraGen, Myriad Genetics, Protagen, Qiagen, PerkinElmer, Merck Millipore, Bio-Rad Laboratories, Enzo Biochem, EKF Diagnostics, Meso Scale Diagnostics, LLC., Targeted Biomarke.
The targeted biomarker market is expected to register a CAGR of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Targeted Biomarker Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Targeted Biomarker Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Targeted Biomarker Market - Supply Chain
4.5. Global Targeted Biomarker Market Forecast
4.5.1. Targeted Biomarker Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Targeted Biomarker Market Size (000 Units) and Y-o-Y Growth
4.5.3. Targeted Biomarker Market Absolute $ Opportunity
5. Global Targeted Biomarker Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Targeted Biomarker Market Size and Volume Forecast by Type
5.3.1. Safety biomarker
5.3.2. Efficacy biomarker
5.3.3. Validation biomarker
5.3.4. Targeted Biomarke
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Targeted Biomarker Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Targeted Biomarker Market Size and Volume Forecast by Application
6.3.1. Diagnostics development
6.3.2. Drug discovery & development
6.3.3. Personalized medicine
6.3.4. Disease risk assessment
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Targeted Biomarker Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Targeted Biomarker Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Targeted Biomarker Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Targeted Biomarker Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Targeted Biomarker Demand Share Forecast, 2019-2026
9. North America Targeted Biomarker Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Targeted Biomarker Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Targeted Biomarker Market Size and Volume Forecast by Application
9.4.1. Diagnostics development
9.4.2. Drug discovery & development
9.4.3. Personalized medicine
9.4.4. Disease risk assessment
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Targeted Biomarker Market Size and Volume Forecast by Type
9.7.1. Safety biomarker
9.7.2. Efficacy biomarker
9.7.3. Validation biomarker
9.7.4. Targeted Biomarke
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Targeted Biomarker Demand Share Forecast, 2019-2026
10. Latin America Targeted Biomarker Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Targeted Biomarker Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Targeted Biomarker Market Size and Volume Forecast by Application
10.4.1. Diagnostics development
10.4.2. Drug discovery & development
10.4.3. Personalized medicine
10.4.4. Disease risk assessment
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Targeted Biomarker Market Size and Volume Forecast by Type
10.7.1. Safety biomarker
10.7.2. Efficacy biomarker
10.7.3. Validation biomarker
10.7.4. Targeted Biomarke
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Targeted Biomarker Demand Share Forecast, 2019-2026
11. Europe Targeted Biomarker Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Targeted Biomarker Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Targeted Biomarker Market Size and Volume Forecast by Application
11.4.1. Diagnostics development
11.4.2. Drug discovery & development
11.4.3. Personalized medicine
11.4.4. Disease risk assessment
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Targeted Biomarker Market Size and Volume Forecast by Type
11.7.1. Safety biomarker
11.7.2. Efficacy biomarker
11.7.3. Validation biomarker 11.7.4. Targeted Biomarke
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Targeted Biomarker Demand Share, 2019-2026
12. Asia Pacific Targeted Biomarker Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Targeted Biomarker Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Targeted Biomarker Market Size and Volume Forecast by Application
12.4.1. Diagnostics development
12.4.2. Drug discovery & development
12.4.3. Personalized medicine
12.4.4. Disease risk assessment
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Targeted Biomarker Market Size and Volume Forecast by Type
12.7.1. Safety biomarker
12.7.2. Efficacy biomarker
12.7.3. Validation biomarker
12.7.4. Targeted Biomarke
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Targeted Biomarker Demand Share, 2019-2026
13. Middle East & Africa Targeted Biomarker Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Targeted Biomarker Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Targeted Biomarker Market Size and Volume Forecast by Application
13.4.1. Diagnostics development
13.4.2. Drug discovery & development
13.4.3. Personalized medicine
13.4.4. Disease risk assessment
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Targeted Biomarker Market Size and Volume Forecast by Type
13.7.1. Safety biomarker
13.7.2. Efficacy biomarker
13.7.3. Validation biomarker
13.7.4. Targeted Biomarke
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Targeted Biomarker Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Targeted Biomarker Market: Market Share Analysis
14.2. Targeted Biomarker Distributors and Customers
14.3. Targeted Biomarker Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. bioMerieux
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. IntegraGen
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Myriad Genetics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Protagen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Qiagen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PerkinElmer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck Millipore
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio-Rad Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Enzo Biochem
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. EKF Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Meso Scale Diagnostics, LLC.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Targeted Biomarke
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
